Pegram, M. D., Borges, V. F., Ibrahim, N., Fuloria, J., Shapiro, C., Perez, S., . . . Courtenay Luck, N. (2009). Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer. BioMed Central.
استشهاد بنمط شيكاغوPegram, Mark D., Virginia F. Borges, Nuhad Ibrahim, Jyotsna Fuloria, Charles Shapiro, Susan Perez, Karen Wang, Franziska Schaedli Stark, و Nigel Courtenay Luck. Phase I Dose Escalation Pharmacokinetic Assessment of Intravenous Humanized Anti-MUC1 Antibody AS1402 in Patients With Advanced Breast Cancer. BioMed Central, 2009.
MLA استشهادPegram, Mark D., et al. Phase I Dose Escalation Pharmacokinetic Assessment of Intravenous Humanized Anti-MUC1 Antibody AS1402 in Patients With Advanced Breast Cancer. BioMed Central, 2009.